Effects of DP-1904, a thromboxane synthetase inhibitor, on the antigen-induced airway hyperresponsiveness and infiltration of inflammatory cells in guinea-pigs

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 59, Issue 6, 1998, Pages 407-414

  Takami, M ^a   Tsukada, W ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIGEN; NAFAGREL; THROMBOXANE B2; THROMBOXANE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; GUINEA PIG; INFLAMMATORY CELL; LUNG LAVAGE; LUNG RESISTANCE; LYMPHOCYTE; MALE; NEUTROPHIL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032462316     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(98)90103-X     Document Type: Article

References (44)

1. 1. Chung K. F. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 1986; 41: 657-662.
2. 2. Barnes P. J. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989; 83: 1026-1031.
3. 3. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72: 2994-2998.
4. 4. Higgs G. A., Moncada S., Salmon J. A. The source of thromboxane and prostaglandin in experimental inflammation. Br J Pharmacol 1983; 79: 863-868.
5. 5. Fox C. C., Kagey-Sobotka A., Schleimer R. P., Peters S. P., MacGlashan D. W. Jr., Lichtenstein L. M. Mediator release from human basophils and mast cells from lung and intestinal mucosa. Int Arch Allergy Appl Immunol 1985; 77: 130-136.
6. 6. Foegh M. L., Maddox Y. T., Ramwell P. W.: Human peritoneal eosinophils and formation of arachidonate cyclooxgenase products. Scand J Immunol 1986; 23: 599-603.
7. 7. Iwamoto I., Ra C., Sato T., Tomioka H., Yoshida S. Thromboxane A2 production in allergen-induced immediate and late asthmatic responses. J Asthma 1988; 25: 117-124.
8. 8. Wenzel S. E., Westcott J. Y., Simth H. R., Larsen G. L.: Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatic and in control groups. Am Rev Respir Dis 1989; 139: 450-457.
9. 9. Aizawa H., Chung K. F., Leikauf G. D. et al. Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. J Appl Physiol 1985; 59: 1918-1923.
10. 2 antagonist L655,240 in the concious primate (Abstract). Am Rev Respir Dis 1988; 137: 100A.
11. 2) in guinea-pig. J Asthma 1989; 26: 237-242.
12. 2 in development of PAF-induced nonspecific airway hyperresponsiveness. Jpn J Pharmacol 1990; 52: 612-630.
13. 13. Jones G. L., Saroea H. G., Watson R. M., O'Byrne P. M. Effect of an inhaled thromboxane mimetic (U-46619) on airway function in human subjects. Am Rev Respir Dis 1992; 145: 1270-1274.
14. 2 in hyperresponsiveness of isolated rat lung tissue in a Sephadex-induced eosinophilia model. Int Arch Allergy Immunol 1995; 106: 401-409.
15. 15. Chung K. F., Aizawa H., Becker A. B., Frick O., Gold W. M., Nadel J. A. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs. Am Rev Rispir Dis 1986; 134: 258-261.
16. 16. Abraham W. M., Stevenson J. S., Garrido R. A leukotriene and thromboxane inhibitor (Sch 37224) blocks antigen-induced immediate and late responses and airway hyperresponsiveness in allergic sheep. J Pharmacol Exp Ther 1988; 247: 1004-1011.
17. 17. Itoh K., Takahashi E., Mukaiyama O., Satoh Y., Yamaguchi T. Effect of a thromboxane synthetase inhibitor (CS-518) on the eosinophil-dependent late asthmatic response and airway hyperresponsiveness in guinea-pigs. Int Arch Allergy Immunol 1996; 109; 79-85.
18. 18. Fujimura M., Sasaki F., Nakatsumi Y. et al. Effect of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 1986; 41: 955-959.
19. 19. Fujimura M., Mishioka S., Kumabashiri I., Matsuda T., Mifune J. Effect of aerosol administration of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to acetylcholine in asthmatic subjects. Chest 1990; 98: 276-279.
20. 20. Fujimura M., Sakamoto S., Saito M., Miyake Y., Matsuda T. Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. J Allergy Clin Immunol 1991; 87: 23-27.
21. 2 synthetase inhibitors. 2. Synthesis and activities of tetrahydronaphthalene and indan derivatives. J Med Chem 1989; 32: 1326-1334.
22. 22. Tanaka M., Ono K., Takegoshi T. et al. The pharmacokinetics and pharmacodynamics of a new thromboxane A2 synthetase inhibitor, 6-(1-imidazolylmethyl)-5, 6, 7, 8-tetrahydronaphthalene-2-carboxylic acid HCl (DP-1904), in man after single oral administration. J Pharm Pharmacol 1989; 41: 680-684.
23. 2 synthetase inhibitor, on guinea-pig experimental asthma. Ann NY Acad Sci 1991; 629: 407-409.
24. 24. Dworski R., FitzGerald G. A., Sheller J. R. Thromboxane synthetase inhibiton in allergen challenged sheep lung: effect on eicosanoidsynthesis. Eicosanoids 1992; 5: 35-37.
25. 25. Trochtenberg D. S., Lefferts P. L., King G. A., Hwang Y. S., Christman B. W., Snapper J. R. Effect of thromboxane synthetase and cyclooxygenase inhibiton on PAF-induced changes in lung function and arachidonic acid metabolism. Prostaglandins 1992; 44: 555-577.
26. 2 synthetase inhibitor, DP-1904, prevents rat renal injury. Eur J Pharmacol 1991; 193: 321-327.
27. 27. Masumura H., Kunitada S., Irie K., Ashida S., Abe Y. A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathy. Eur J Pharmacol 1992; 210: 163-172.
28. 28. Randon J., Lefort J., Bargaftig B. Blockade by methlation inhibitors of the anaphylactic response of guinea-pig lung strips. Br J Pharmacol 1987; 92: 683-691.
29. 29. Konzett H., Rossler R. Versuchanordnung zu untersuchengen an der bronchialmuskulater. Arch Exp Path Pharmak 1940; 195: 71-74.
30. 30. Iijima H., Ishii M., Yamauchi K. et al. Bronchoalveolar lavage and histological characterization of late asthmatic response in guinea-pigs. Am Rev Respir Dis 1987; 136: 922-929.
31. 31. Hyatt R. E., Zimmerman I. R., Peter G. M., Sullivan W. J. Direct writeout of respiratory resistance. J Appl Physiol 1987; 28: 675-678.
32. 32. Rogers D. F., Boschetto P., Barnes P. J. Plasma exduation: correlation between Evans blue dye and radiolabelled albumin in guinea-pig airways in vivo. J Pharmcol Methods 1989; 21: 309-313.
33. 2 synthetase inhibitor (OKY-046/HCl) on airway hyperresponsiveness in guinea-pigs. Eur J Pharmacol 1990; 184: 87-95.
34. 34. Yamaguchi T., Mukaiyama O., Itoh K., Satoh Y., Terada A., Iizuka Y. Effect of CS-518, a thromboxane synthetase inhibitor, on asthmatic response. Eur J Pharmacol 1993; 236: 159-169.
35. 35. Persson C. G. A. Role of plasma exduation in asthmatic airway. Lancet 2, 1986; 39: 1126-1129.
36. 36. Kimura K. et al. Bradykinin causes airway hyperresponsiveness and enhances maximal airway narrowing. Am Rev Respir Dis 1992; 146: 1301-1305.
37. 37. Hui K. P., Lotvall J., Chung K. F., Barnes P. J. Attenuation of inhaled allergen-induced airway microvascular leakage and airflow obstraction in guinea-pig by a 5-lipoxgenase inhibitor (A-63163). Am Rev Respir Dis 1991; 143: 1015-1019.
38. 2, and prostacyclin. Pharamacol Rev 1979; 30: 293-331.
39. 39. Lotvall J., Elwood W., Tokuyama K., Sakamoto T., Barnes P. J., Chung K. F. A thromboxane mimetic, U-46619, produces plasma exduation in airways of the guinea-pig. J Appl Physiol 1992; 76: 2415-2419.
40. 40. Frew A. J., Moqbel R., Azzawi M. et al. T lymphocytes and eosinophils in allergen-induced late phase asthmatic reactions in the guinea-pig. Am Rev Respir Dis 1990; 141: 407.
41. 41. Agrawal D. K., Takami M., Ono S. DP-1904, a novel thromboxane synthetase inhibitor, attenuates the effect of inflammatory mediators in human monocytes and lymphocytes (Abstract). Am Rev Rispir Dis 1993; 147: A448.
42. 42. Butchers P. R., Vardey C. J. The effect of prostanoids on the function of human eosinophils. Agents and Actions 1990; 31: 103-112.
43. 43. Dworski R., Fitzgerald G. A., Sheller J. R. Thromboxane synthetase inhibitor in allergen challenged sheep lung: effect on eicosanoid synthesis. Eicosanoid 1992; 5: 35-37.
44. 44. Agrawal D. K., Takami M., Ono S. A novel thrombxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation. Inflammation 1997; 21: 1-8.